Lupin Limited (Biotech Division) – FDA 483, Oct 14, 2022
Lupin Limited (Biotech Division) in Pune, India, was inspected by the FDA from October 3-14, 2022, and received 18 observations. The inspection revealed significant deficiencies in aseptic processing, environmental monitoring, quality control, and facility maintenance for drug substance and drug product manufacturing. These issues indicate a lack of adequate controls to prevent contamination and ensure product quality and purity.
ID · fba695c4-7c84-4c77-be5a-4e943aef6afb
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.